Dr Martens /DOCS

-0.1%
-
1D1W1MYTD1YMAX

About Dr Martens

Dr. Martens plc is a United Kingdom-based company, which designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company operates through three reporting segments: Europe, the Middle East and Africa (EMEA); Americas; and Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels, and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes Originals, Fusion, and Casual collections. It offers various accessories, such as shoe care, laces and socks, leather bags and small leather items. It operates in over 60 countries globally, through a range of modes: directly operated stores and ecommerce sites, wholesale partners and distributors.
Ticker
DOCS
Sector
Consumer Cyclicals
Trading on
LSE
Industry
Footwear
CEO
Kenny Wilson
Employees
2,591
Headquarters
London, United Kingdom

Dr Martens Metrics

BasicAdvanced
£938.53M
Market cap
9.47
P/E ratio
£0.10
EPS
-
Beta
£0.06
Dividend rate
5.98%
Dividend yield

What the Analysts think about Dr Martens

Analyst Ratings

Majority rating from 9 analysts.
Hold

Price Targets

Average projection from 9 analysts.
0% downside
High £1.10
Low £0.85
£0.98
Current price
£0.98
Average price target

Dr Martens Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
4.8% profit margin
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
£395.8M
-31.96%
Net income
£19M
-77.43%
Profit margin
4.8%
-66.83%

Dr Martens Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 39.19%
QuarterlyAnnual
Q1 22
Q3 23
Q1 23
Q3 24
Q1 24
Actual
£0.13
£0.05
£0.08
£0.02
-
Expected
£0.10
£0.05
£0.10
£0.01
£0.08
Surprise
27.76%
-4.05%
-14.02%
39.19%
-
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and LSEG. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Dr Martens  stock

Buy or sell Dr Martens stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing